PEBRILZO
BIOCON BIOLOGICS INC · PERTUZUMAB
Open FDA's page for this record- Application number
- BLA761501
- Sponsor name
- BIOCON BIOLOGICS INC
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20261112
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 87692
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761501s000lbl.pdf
- Date
- 20261113
- Type
- Label
- ID
- 87696
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761501Orig1s000ltr.pdf
- Date
- 20261113
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- PEBRILZO
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- INJECTION
- Marketing status
- Prescription
- Active ingredients
- Name
- PERTUZUMAB
- Strength
- 420MG/14ML (30MG/ML)
